Channa Jayasena is a Clinical Senior Lecturer and Consultant in Reproductive Endocrinology and Andrology at Imperial College and Hammersmith Hospital, London. Dr. Jayasena qualified in medicine at Cambridge University, after which he undertook specialist training in Diabetes & Endocrinology in London. Having been awarded a Wellcome Trust Clinical Research Training Fellowship and NIHR Clinical Lectureship, he conducted first-to-human studies at Imperial College investigating the clinical effects of novel hypothalamic neuropeptides such as kisspeptin on the human reproductive axis. He is currently Clinical Lead for Male Infertility / Andrology at Hammersmith Hospital which has developed cutting edge techniques such as seminal reactive oxygen species (ROS) measurement, microsurgical testicular sperm extraction (mTESE) and testicular mapping. His current research focuses on developing novel diagnostics and therapeutics for men and women with disorders of reproduction.
Dimakopoulou A, Jayasena CN, 2018, Seminal reactive oxygen species, a novel biochemical assay for testing male fertility?, Biochemist, Vol:40, ISSN:0954-982X, Pages:12-13
et al., 2018, Multiple primary malignancies and prolonged survival in a patient with widespread metastatic cutaneous melanoma, Melanoma Research, Vol:28, ISSN:0960-8931, Pages:163-166
et al., 2018, Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action., Menopause
Ali SN, Jayasena CN, Sam AH, 2018, Which patients with gynaecomastia require more detailed investigation?, Clinical Endocrinology, Vol:88, ISSN:0300-0664, Pages:360-363
et al., 2018, Testosterone therapy for sexual dysfunction in men with Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials, Diabetic Medicine, Vol:35, ISSN:0742-3071, Pages:195-202